Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Condition(s):Inherited Bone Marrow Failure Syndrome; Familial Platelet Disorder With Predisposition to Myeloid MalignanciesLast Updated:January 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Inherited Bone Marrow Failure Syndrome; Familial Platelet Disorder With Predisposition to Myeloid MalignanciesLast Updated:January 5, 2024Recruiting
Condition(s):Lung Diseases; Bronchitis, ChronicLast Updated:October 28, 2014Completed
Condition(s):Foot Ulcer, Diabetic; Diabetic FootLast Updated:September 27, 2012Completed
Condition(s):Multiple SclerosisLast Updated:June 24, 2013Completed
Condition(s):Nosocomial PneumoniaLast Updated:March 8, 2024Completed
Condition(s):OsteoarthritisLast Updated:December 17, 2014Completed
Condition(s):Post-COVID-19 SyndromeLast Updated:May 1, 2023Recruiting
Condition(s):Obstructive Sleep Apnea; OSA; Apnea; Apnea, Obstructive; Apnea, Obstructive Sleep; Apnea+Hypopnea; Hypopnea, SleepLast Updated:February 8, 2023Recruiting
Condition(s):Tuberculous UveitisLast Updated:February 23, 2024Enrolling by invitation
Condition(s):Proctitis, UlcerativeLast Updated:August 28, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.